Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Mr. Benjamin NicholsChief Commercial Officer | -195,00 | 5,65k | Derivative Exercise and Sale | 28,97 | 14,44k | - |
| 2026-05-18 | Mr. Benjamin NicholsChief Commercial Officer | 490,00 | 0,00 | Derivative Exercise and Retained Stock | - | 14,44k | 3,51% |
| 2026-05-13 | Mr. Benjamin NicholsChief Commercial Officer | -247,00 | 7,46k | Derivative Exercise and Sale | 30,21 | 13,95k | - |
| 2026-05-13 | Mr. Benjamin NicholsChief Commercial Officer | 490,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,95k | 3,64% |
| 2026-03-05 | Mr. Richard P. DealyIndependent Director | 11,91k | 0,00 | Derivative Exercise and Retained Stock | - | 43,56k | 37,61% |
| 2026-03-05 | Ms. Lori Ann WalkerInitié | 11,91k | 0,00 | Derivative Exercise and Retained Stock | - | 58,72k | 25,43% |
| 2026-03-05 | Mr. Joseph E. ReeceIndependent Non-Executive Chairman of the Board | 22,32k | 0,00 | Derivative Exercise and Retained Stock | - | 43,32k | 106,30% |
| 2026-03-05 | Mr. Gareth T. JoyceIndependent Director | 11,91k | 0,00 | Derivative Exercise and Retained Stock | - | 43,12k | 38,14% |
| 2026-03-05 | Ms. Melissa M. MillerIndependent Director | 11,91k | 0,00 | Derivative Exercise and Retained Stock | - | 43,15k | 38,10% |
| 2026-03-03 | Mr. Patrick James MerrinCOO | 13,52k | 0,00 | Derivative Exercise and Retained Stock | - | 13,52k | - |
| 2026-03-03 | Mr. Patrick James MerrinCOO | -5,00k | 123,47k | Derivative Exercise and Sale | 24,68 | 13,52k | - |
| 2026-01-28 | Mr. Peter FjellmanCFO | 5,60k | 0,00 | Derivative Exercise and Retained Stock | - | 5,60k | - |
| 2026-01-28 | Mr. Peter FjellmanCFO | -2,72k | 70,45k | Derivative Exercise and Sale | 25,90 | 5,60k | - |
| 2026-01-18 | Dr. Edward C. DowlingPresident, CEO & Director | 15,47k | 0,00 | Derivative Exercise and Retained Stock | - | 66,26k | 30,46% |
| 2026-01-18 | Dr. Edward C. DowlingPresident, CEO & Director | -6,88k | 160,19k | Derivative Exercise and Sale | 23,29 | 66,26k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.